05/30/2023 | Sponsored by Okuvision | 7 min read
Florian Gekeler and Okuvision CEO, Alfred Stett, discuss Okuvision’s role in developing OkuStim therapy for retinitis pigmentosa patients
12/08/2022 | Sponsored by Okuvision | 2 min read
Okuvision develop an at home treatment that slows the progression of degenerative retinal disease
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Landmark nAMD Treatment
Verifying Your Vision and Values
Pushing Back on BAK
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: